Market Analysis: Europe Biopsy Devices Market
Market Definition: Europe Biopsy Devices Market
Biopsy is a medical test conducted to evaluate and eliminate the body's cancer tissue. Biopsy is often used to obtain tissue sample to diagnose the disease when a patient is presumed of having cancer. There are different kinds of biopsy used in cancer diagnosis, including skin biopsy, fine needle aspiration, vacuum biopsy, shave biopsy, incision and excision biopsy, and needle biopsy. In needles, mechanical biopsy devices and biopsy guides, along with technological advances in significant computed tomography (CT) and ultrasonography (US) imaging techniques, there have been constant improvements.
Get More Insights About Europe Biopsy Devices Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-biopsy-devices-market
Increasing incidents of cancer, is driving the growth of the market
Increasing government initiatives, is helping in the growth of the market
Surging demand for minimally invasive surgeries, are the major factor for the growth of the market
Technological advancement in the field of biopsy devices, drives the market growth
Strict standards and regulation for the use of biopsy, hinders the growth of the market
Expensive biopsy devices, also restricts the growth of the market
Increasing complaints to breast cancer screening procedure, impeding growth of the market
Segmentation: Europe Biopsy Devices Market
Needle-Based Biopsy Instruments
Core Biopsy Devices
Aspiration Biopsy Needles
Vacuum-Assisted Biopsy Devices
By Guidance Technique
Other Guidance Techniques
By End User
Academic and Research Institutes
Diagnostic and Imaging Centers
Rest of Europe
Know more about this report https://www.databridgemarketresearch.com/reports/europe-biopsy-devices-market
Key Developments in the Market:
In April 2019, Hologic Inc. introduced Trident HD Specimen Radiography System. It was launched in Canada, Europe and United States. It is a next-generation product that provides improved picture quality, enhanced workflow and immediate test results during breast-conserving operations and stereotactic breast biopsies. With this launch the company expanded its product portfolio and offerings.
In February 2019, Lunaphore has created a bit of next-generation immunohistochemistry (IHC) testing machinery, a popular method used to detect particular cancer biomarkers in the tissue samples from cancer patients following a biopsy. The device, known as LabSat, will be accessible for study apps in most European nations. A regular IHC test can be performed with LabSat in 10-30 minutes. This can have a enormous effect on the scheduling of study studies, particularly when many distinct protocols need to be optimized. LabSat enables tiny changes of the circumstances to be quickly tried one after the other.
Key Market Competitors:
Few of the major market competitors currently working in the Europe biopsy devices market are BD, Cook Group, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, , Scion Medical Technologies, LLC, STERYLAB S.r.l., EndoMed Systems Alle Rechte vorbehalten, TSK Laboratory Europe B.V., B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, SRL Diagnostics among others.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-biopsy-devices-market
Browse Trending Related Reports @
About Data Bridge Market Research: